Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_assertion description "[Lymphocytes from patients with acute lymphocytic leukemia (T-ALL) showed an enzyme profile similar to that of normal thymocytes, i.e., an elevated level of adenosine deaminase (ADA) activity as compared with normal T lymphocytes, reduced activities of purine 5'nucleotidase (5'NT) and purine nucleoside phosphorylase (PNP), and a binomial distribution of the LDH isoenzyme pattern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_assertion evidence source_evidence_literature NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_assertion SIO_000772 6309282 NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_assertion wasDerivedFrom befree-20140225 NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_assertion wasGeneratedBy ECO_0000203 NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP408307.RAT9Ku61I79L3cEhwfv_v56bDzSFNNN7vGvKT16FrhUHs130_provenance.